Medical Countermeasures New Insights Into Tularemia Pathogen May Inform Next-Generation Medical CountermeasuresGlobal Biodefense StaffMay 14, 2026
Medical Countermeasures When Mpox Strikes the Eye: A Case for Combination Antiviral TherapyGlobal Biodefense StaffApril 16, 2026
Medical Countermeasures Smallpox Preparedness Contracts Top $60 Million as U.S. and International Partners Bolster Biodefense StockpilesGlobal Biodefense StaffMarch 25, 2026
MGB Biopharma Receives 6.4M to Advance Novel Antibacterial Antimicrobial Resistance September 18, 2014 …
Antimicrobial Strategy Silences Resistant Gene in Pathogens Antimicrobial Resistance September 8, 2014 …